{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:53Z","timestamp":1787166713839,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biosynex SA"},{"name":"Sant\u00e9 publique France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Group B\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      (GBS) is the leading cause of invasive infections in newborns. The prevention of GBS neonatal disease relies on the administration of an\n                      <jats:italic>intrapartum<\/jats:italic>\n                      antibiotic prophylaxis to GBS-colonized women. In recent years, rapid\n                      <jats:italic>intrapartum<\/jats:italic>\n                      detection of GBS vaginal colonization using real-time nucleic acid amplification tests (NAATs) emerged as an alternative to antenatal culture screening methods.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared the performances of two loop-mediated isothermal amplification (LAMP) tests, the Ampliflash\u00ae GBS and the PlusLife\u00ae GBS tests, to standard culture for GBS detection in vaginal specimens from pregnant women. The study was conducted from April to July 2023 in a French hospital of the Paris area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 303 samples were analyzed, including 85 culture-positive samples (28.1%). The Ampliflash\u00ae GBS test and the PlusLife\u00ae GBS tests gave a result for 100% and 96.3% tests, respectively. The performances of the tests were as follows: sensitivity 87.1% (95% confidence interval (CI) 78.3\u201392.6) and 98.7% (95% CI 93.0-99.8), specificity 99.1% (95% CI 96.7\u201399.8), and 91.9% (95% CI 87.3\u201395.0), respectively. False negative results of the Ampliflash\u00ae GBS test correlated with low-density GBS cultures. Time-to-results correlated with GBS culture density only for the PlusLife\u00ae GBS test (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both techniques provide excellent analytical performances with high sensitivity and specificity together with a short turnaround time and results available in 10 to 35\u00a0min. Their potential to further reduce the burden of GBS neonatal disease compared with antenatal culture screening needs to be assessed in future clinical studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-024-00695-2","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:03:27Z","timestamp":1714043007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Performances of two rapid LAMP-based techniques for the intrapartum detection of Group B Streptococcus vaginal colonization"],"prefix":"10.1186","volume":"23","author":[{"given":"Rym","family":"Charfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Guyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiggie","family":"Untrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Giacometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Paper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Poyart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Plainvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Tazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"695_CR1","doi-asserted-by":"publisher","unstructured":"Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis 2017 6;65:S200\u201319. https:\/\/doi.org\/10.1093\/cid\/cix664.","DOI":"10.1093\/cid\/cix664"},{"key":"695_CR2","doi-asserted-by":"publisher","unstructured":"Plainvert C, de Saint Salvy-Tabet Y, Dmytruk N, Frigo A, Poyart C, Tazi A, Group B. Streptococcus (GBS) invasive infections in women of childbearing age, France, 2012\u20132020: GBS CC-17 hypervirulence in intrapartum infections. J. Infect. Dis. 2022 26;226:541\u20135. https:\/\/doi.org\/10.1093\/infdis\/jiac076.","DOI":"10.1093\/infdis\/jiac076"},{"key":"695_CR3","first-page":"1","volume":"19","author":"JR Verani","year":"2010","unstructured":"Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease\u2013revised guidelines from CDC, 2010. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2010;19:59:1\u201336.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"695_CR4","doi-asserted-by":"publisher","unstructured":"Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 2013 28;31 Suppl 4:D20-26. https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.056.","DOI":"10.1016\/j.vaccine.2012.11.056"},{"key":"695_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","volume":"1","author":"SA Nanduri","year":"2019","unstructured":"Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: Multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;1:173:224. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.4826.","journal-title":"JAMA Pediatr"},{"key":"695_CR6","unstructured":"HAS. Pr\u00e9vention ant\u00e9natale du risque infectieux bact\u00e9rien n\u00e9onatal pr\u00e9coce [Internet]. 2001;doi: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/prevention_antenatale_du_risque_infectieux_bacterien_-_rec.pdf."},{"key":"695_CR7","unstructured":"Prevention of perinatal group B streptococcal infections Guidelines from the Belgian Health Council. 2003 [Internet]. 2003;doi: https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/4448391\/Prevention%20of%20perinatal%20group%20B%20streptococcal%20infections%20%28April%202003%29%20%28SHC%207721%29.pdf."},{"key":"695_CR8","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","volume":"135","author":"Prevention of Group B Streptococcal Early-Onset Disease in Newborns","year":"2020","unstructured":"Prevention of Group B Streptococcal Early-Onset Disease in Newborns. ACOG Committee Opinion, Number 797. Obstet. Gynecol. 2020;135:e51\u201372. https:\/\/doi.org\/10.1097\/AOG.0000000000003668.","journal-title":"Gynecol"},{"key":"695_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/s-0043-105207","volume":"221","author":"A Franz","year":"2017","unstructured":"Franz A, H\u00e4rtel C, Herting E, Kehl S, Gille C, Doubek K, et al. Prophylaxe Der Neugeborenensepsis \u2013 fr\u00fche form \u2013 durch Streptokokken Der Gruppe B. Leitlinie Des BVF, BVDfK, Der DGGG, DGHM, DGPI, DGPM Und GNPI. (S2k-Level, AWMF-Registernummer 024\/020, M\u00e4rz 2016. Z F\u00fcr Geburtshilfe Neonatol. 2017;221:122\u20139. https:\/\/doi.org\/10.1055\/s-0043-105207.","journal-title":"Z F\u00fcr Geburtshilfe Neonatol"},{"key":"695_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.eimc.2012.03.013","volume":"31","author":"JI Al\u00f3s Cort\u00e9s","year":"2013","unstructured":"Al\u00f3s Cort\u00e9s JI, Andreu Domingo A, Arribas Mir L, Cabero Roura L, De Cueto L\u00f3pez M, L\u00f3pez Sastre J, et al. Prevenci\u00f3n De La infecci\u00f3n perinatal por estreptococo del grupo B. Recomendaciones espa\u00f1olas. Actualizaci\u00f3n 2012. Microbiol Cl\u00ednica. 2013;31:159\u201372. https:\/\/doi.org\/10.1016\/j.eimc.2012.03.013. Documento de consenso SEIMC\/SEGO\/SEN\/SEQ\/SEMFYC. Enfermedades Infecc.","journal-title":"Microbiol Cl\u00ednica"},{"key":"695_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/s0029-7844(02)02097-5","volume":"100","author":"RK Edwards","year":"2002","unstructured":"Edwards RK, Clark P, Duff P. Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates. Obstet Gynecol. 2002;100:540\u20134. https:\/\/doi.org\/10.1016\/s0029-7844(02)02097-5.","journal-title":"Obstet Gynecol"},{"key":"695_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1086\/600303","volume":"49","author":"N El Helali","year":"2009","unstructured":"El Helali N, Nguyen J, Ly A, Giovangrandi Y, Trinquart L. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B Streptococcus screening. Clin Infect Dis. 2009;49:417\u201323. https:\/\/doi.org\/10.1086\/600303.","journal-title":"Clin Infect Dis"},{"key":"695_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10096-017-3125-2","volume":"37","author":"C Plainvert","year":"2018","unstructured":"Plainvert C, El Alaoui F, Tazi A, Joubrel C, Anselem O, Ballon M, et al. Intrapartum group B Streptococcus screening in the labor ward by Xpert\u00ae GBS real-time PCR. Eur J Clin Microbiol Infect Dis. 2018;37:265\u201370. https:\/\/doi.org\/10.1007\/s10096-017-3125-2.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"695_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1542\/peds.2004-2275","volume":"115","author":"KM Puopolo","year":"2005","unstructured":"Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115:1240\u20136. https:\/\/doi.org\/10.1542\/peds.2004-2275.","journal-title":"Pediatrics"},{"key":"695_CR15","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1056\/NEJMoa0806820","volume":"18","author":"MK Van Dyke","year":"2009","unstructured":"Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B Streptococcus. N Engl J Med. 2009;18:360:2626\u201336. https:\/\/doi.org\/10.1056\/NEJMoa0806820.","journal-title":"N Engl J Med"},{"key":"695_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cmi.2015.05.039","volume":"21","author":"C Joubrel","year":"2015","unstructured":"Joubrel C, Tazi A, Six A, Dmytruk N, Touak G, Bidet P, et al. Group B Streptococcus neonatal invasive infections, France 2007\u20132012. Clin Microbiol Infect. 2015;21:910\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2015.05.039.","journal-title":"Clin Microbiol Infect"},{"key":"695_CR17","doi-asserted-by":"publisher","unstructured":"Di Renzo GC, Melin P, Berardi A, Blennow M, Carbonell-Estrany X, Donzelli GP et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J. Matern. Fetal Neonatal Med. 2015 3;28:766\u201382. https:\/\/doi.org\/10.3109\/14767058.2014.934804.","DOI":"10.3109\/14767058.2014.934804"},{"key":"695_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/clinchem\/46.3.324","volume":"46","author":"D Ke","year":"2000","unstructured":"Ke D, M\u00e9nard C, Picard FJ, Boissinot M, Ouellette M, Roy PH, et al. Development of conventional and real-time PCR assays for the rapid detection of group B Streptococci. Clin Chem. 2000;46:324\u201331.","journal-title":"Clin Chem"},{"key":"695_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1086\/424518","volume":"15","author":"HD Davies","year":"2004","unstructured":"Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis. 2004;15:39:1129\u201335. https:\/\/doi.org\/10.1086\/424518.","journal-title":"Clin Infect Dis"},{"key":"695_CR20","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1128\/JCM.00947-10","volume":"48","author":"J Riedlinger","year":"2010","unstructured":"Riedlinger J, Beqaj SH, Milish MA, Young S, Smith R, Dodd M, et al. Multicenter evaluation of the BD Max GBS assay for detection of group B streptococci in prenatal vaginal and rectal screening swab specimens from pregnant women. J Clin Microbiol. 2010;48:4239\u201341. https:\/\/doi.org\/10.1128\/JCM.00947-10.","journal-title":"J Clin Microbiol"},{"key":"695_CR21","doi-asserted-by":"publisher","first-page":"e01958","DOI":"10.1128\/JCM.01958-18","volume":"57","author":"JH Shin","year":"2019","unstructured":"Shin JH, Pride DT. Comparison of three nucleic acid amplification tests and culture for detection of group B Streptococcus from enrichment broth. J Clin Microbiol. 2019;57:e01958\u201318. https:\/\/doi.org\/10.1128\/JCM.01958-18.","journal-title":"J Clin Microbiol"},{"key":"695_CR22","doi-asserted-by":"publisher","first-page":"651968","DOI":"10.3389\/fcimb.2021.651968","volume":"24","author":"K Gao","year":"2021","unstructured":"Gao K, Deng Q, Huang L, Chang C-Y, Zhong H, Xie Y, et al. Diagnostic performance of various methodologies for group B Streptococcus screening in pregnant woman in China. Front Cell Infect Microbiol. 2021;24:11:651968. https:\/\/doi.org\/10.3389\/fcimb.2021.651968.","journal-title":"Front Cell Infect Microbiol"},{"key":"695_CR23","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.micinf.2006.02.008","volume":"8","author":"M-C Lamy","year":"2006","unstructured":"Lamy M-C, Dramsi S, Billo\u00ebt A, R\u00e9glier-Poupet H, Tazi A, Raymond J, et al. Rapid detection of the highly virulent group B Streptococcus ST-17 clone. Microbes Infect. 2006;8:1714\u201322. https:\/\/doi.org\/10.1016\/j.micinf.2006.02.008.","journal-title":"Microbes Infect"},{"key":"695_CR24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1128\/JCM.00261-15","volume":"53","author":"SA Miller","year":"2015","unstructured":"Miller SA, Deak E, Humphries R. Comparison of the AmpliVue, BD Max System, and illumi gene molecular assays for detection of group B Streptococcus in antenatal screening specimens. J Clin Microbiol. 2015;53:1938\u201341. https:\/\/doi.org\/10.1128\/JCM.00261-15.","journal-title":"J Clin Microbiol"},{"key":"695_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1471-0528.2010.02725.x","volume":"118","author":"JP Daniels","year":"2011","unstructured":"Daniels JP, Gray J, Pattison HM, Gray R, Hills RK, Khan KS, et al. Intrapartum tests for group B Streptococcus: accuracy and acceptability of screening. BJOG Int J Obstet Gynaecol. 2011;118:257\u201365. https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02725.x.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"695_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/1471-0528.12138","volume":"120","author":"E Poncelet-Jasserand","year":"2013","unstructured":"Poncelet-Jasserand E, Forges F, Varlet M, Chauleur C, Seffert P, Siani C, et al. Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real\u2010time PCR assay. BJOG Int J Obstet Gynaecol. 2013;120:1098\u2013109. https:\/\/doi.org\/10.1111\/1471-0528.12138.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"695_CR27","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1128\/JCM.01081-14","volume":"52","author":"BA Couturier","year":"2014","unstructured":"Couturier BA, Weight T, Elmer H, Schlaberg R. Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates. J Clin Microbiol. 2014;52:3429\u201332. https:\/\/doi.org\/10.1128\/JCM.01081-14.","journal-title":"J Clin Microbiol"},{"key":"695_CR28","unstructured":"Boyer KM. Group B streptococci: determinants of invasive neonatal infection. Mead Johnson Symp. Perinat. Dev. Med. 1982;47\u201351."},{"key":"695_CR29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/infdis\/145.6.800","volume":"145","author":"JA Hoogkamp-Korstanje","year":"1982","unstructured":"Hoogkamp-Korstanje JA, Gerards LJ, Cats BP. Maternal carriage and neonatal acquisition of group B Streptococci. J Infect Dis. 1982;145:800\u20133.","journal-title":"J Infect Dis"},{"key":"695_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0029-7844(95)00402-5","volume":"87","author":"M Yancey","year":"1996","unstructured":"Yancey M, Duff P, Kubilis P, Clark P, Frentzen B. Risk factors for neonatal sepsis. Obstet Gynecol. 1996;87:188\u201394. https:\/\/doi.org\/10.1016\/0029-7844(95)00402-5.","journal-title":"Obstet Gynecol"},{"key":"695_CR31","doi-asserted-by":"publisher","unstructured":"Xiao Z, Liu X, Kang X, Feng Y, Zheng L, Chen C. Rapid and accurate detection of SARS-CoV-2 using the RHAM technology. Sci Rep 2023 20;13:22798. https:\/\/doi.org\/10.1038\/s41598-023-49733-7.","DOI":"10.1038\/s41598-023-49733-7"},{"key":"695_CR32","unstructured":"American Society for Microbiology. Guidelines for the detection and identification of group B Streptococcus [Internet]. 2021;doi: https:\/\/asm.org\/guideline\/guidelines-for-the-detection-and-identification-of."},{"key":"695_CR33","doi-asserted-by":"publisher","first-page":"106972","DOI":"10.1016\/j.ijid.2024.02.015","volume":"142","author":"S Tonen-Wolyec","year":"2024","unstructured":"Tonen-Wolyec S, Otuli NL, Otsatre-Okuti M, Atenyi-Kasemire R, Dupont R, B\u00e9lec L. Analytical performances of a point-of-care loop-mediated isothermal amplification assay to detect Group B Streptococcus in intrapartum pregnant women living in the Democratic Republic of the Congo. Int J Infect Dis. 2024;142:106972. https:\/\/doi.org\/10.1016\/j.ijid.2024.02.015.","journal-title":"Int J Infect Dis"},{"key":"695_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mimet.2008.02.024","volume":"73","author":"A Tazi","year":"2008","unstructured":"Tazi A, R\u00e9glier-Poupet H, Dautezac F, Raymond J, Poyart C. Comparative evaluation of Strepto B ID\u00aechromogenic medium and Granada media for the detection of Group B Streptococcus from vaginal samples of pregnant women. J Microbiol Methods. 2008;73:263\u20135. https:\/\/doi.org\/10.1016\/j.mimet.2008.02.024.","journal-title":"J Microbiol Methods"},{"key":"695_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1128\/jcm.30.4.1019-1021.1992","volume":"30","author":"M De La Rosa","year":"1992","unstructured":"De La Rosa M, Perez M, Carazo C, Pareja L, Peis JI, Hernandez F. New Granada medium for detection and identification of group B Streptococci. J Clin Microbiol. 1992;30:1019\u201321. https:\/\/doi.org\/10.1128\/jcm.30.4.1019-1021.1992.","journal-title":"J Clin Microbiol"},{"key":"695_CR36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/JCM.05372-11","volume":"50","author":"S Nickmans","year":"2012","unstructured":"Nickmans S, Verhoye E, Boel A, Van Vaerenbergh K, De Beenhouwer H. Possible solution to the problem of nonhemolytic Group B Streptococcus on Granada Medium. J Clin Microbiol. 2012;50:1132\u20133. https:\/\/doi.org\/10.1128\/JCM.05372-11.","journal-title":"J Clin Microbiol"},{"key":"695_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/1471-2334-10-285","volume":"10","author":"NA El Aila","year":"2010","unstructured":"El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H, et al. Comparison of different sampling techniques and of different culture methods for detection of group B Streptococcus carriage in pregnant women. BMC Infect Dis. 2010;10:285. https:\/\/doi.org\/10.1186\/1471-2334-10-285.","journal-title":"BMC Infect Dis"},{"key":"695_CR38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/IDR.S203454","volume":"13","author":"C Carreras-Abad","year":"2020","unstructured":"Carreras-Abad C, Ramkhelawon L, Heath PT, Le Doare K. A vaccine against Group B Streptococcus: recent advances. Infect Drug Resist. 2020;13:1263\u201372. https:\/\/doi.org\/10.2147\/IDR.S203454.","journal-title":"Infect Drug Resist"},{"key":"695_CR39","doi-asserted-by":"publisher","first-page":"2037350","DOI":"10.1080\/21645515.2022.2037350","volume":"31","author":"J Absalon","year":"2022","unstructured":"Absalon J, Simon R, Radley D, Giardina PC, Koury K, Jansen KU, et al. Advances towards licensure of a maternal vaccine for the prevention of invasive group B Streptococcus disease in infants: a discussion of different approaches. Hum Vaccines Immunother. 2022;31:18:2037350. https:\/\/doi.org\/10.1080\/21645515.2022.2037350.","journal-title":"Hum Vaccines Immunother"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-024-00695-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:12:21Z","timestamp":1714043541000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-024-00695-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s12941-024-00695-2","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MU, GG are employees and TP is a corporate executive officer of Biosynex S.A. Other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a molecular-based study in which samples were duly anonymized with no change in the standard of care; therefore, no informed consent was requested.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"37"}}